Volume 44 (2026) – Supplementary Issue 1 – Article 15 – Epitheorese Klinikes Farmakologias kai Farmakokinetikes

Open Access Research

Anti-proliferative activity of a newly synthesized indole derivative on the HUVEC and MCF-7 cell lines
Raghad Shakir Hadid1A green circle with white letters Description automatically generated, Ghaith Ali Jasim Al-Zubaidy1,2*A green circle with white letters Description automatically generated, Basma Talib Al-Sudani1A green circle with white letters Description automatically generated, Asmaa Q. Ibrahim3A green circle with white letters Description automatically generated
1College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
2College of Health and Medical Techniques, Al-Bayan University, Baghdad, Iraq
3Faculty of Allied Medical Sciences/Al-Ahliyya Amman University, Amman, Jordan

*Corresponding author: Ghaith Ali Jassim Al-Zubaidy, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq. College of Health and Medical Techniques, Al-Bayan University, Baghdad, Iraq. Telephone: +9647901965695; email: ghaith.a@albayan.edu.iq


Download PDF

Published: 2026 ; https://doi.org/10.61873/


Abstract
Background: Angiogenesis is the biological process involving the development of new blood vessels from existing ones. Aim: Aim of this study was to investigate the antiproliferative activity of 2-(5-bromo-1H-indole-2-carbonyl)-N-(p-tolyl) hydrazine-1-carbothioamide. Methodology: The anti-proliferative effect on the human umbilical vein endothe¬lial cell line (HUVECs) and MCF-7 cell line was assessed using the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] MTT assay. Expression of VEGFA, VEGFB, and EGF genes was determined by quanti¬tative real-timepolymerase chain reaction(qPCR) and confirmed by agarose gel electrophoresis. Results: The com¬pound inhibits the proliferation of HUVECs with an IC50 of 80.24 μg/mL and MCF-7 with an IC50 of 96.32 μg/mL. Only one biological sample was analyzed for each treatment concentration, and these gene-expression findings was interpreted as preliminary observations, the HUVECs, VEGFA expression was reduced at a concentration of 160.48 μg/mL, with a relative expression level of 0.78 ± 0.63-fold compared with the control group. In MCF-7 cells, EGF expression was also reduced at 192.64 μg/mL, with a relative expression level of 0.88 ± 0.40-fold compared with the control group. The agarose gel electrophoresis image confirmed sharp bands of double-stranded DNA. Conclusion: The findings indicate preliminary antiproliferative activity of the tested compound against HU¬VECs and MCF-7 cells, together with exploratory modulation of angiogenesis-related gene expression. Further stud¬ies with independent biological replicates and functional angiogenesis assays are required to determine the biological significance and anti-angiogenic potential of the compound.

Keywords: MTT assay, HUVECs, MCF-7, VEGF-A, and EGF

Please cite as: 

 


pISSN 1011-6575 • eISSN 2945-1914

Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.